FRA/4AB0 (FRA/4AB0)

Frankfurt Stock Exchange: FRA/4AB0 · EUR

€24.6

-0.20 (-0.8%)· Recorded snapshot

Market cap	454.2B
Revenue (ttm)	56.4B
Net income (ttm)	5.5B
EPS (ttm)	€0.30
P/E (trailing)	81.3x
P/E (forward)	19.1x
Dividend	€0.59 (2.42%)
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 56.4B
Net income (ttm): 5.5B
EPS (ttm): €0.30
P/E (trailing): 81.3x
P/E (forward): 19.1x
Market cap: 454.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E81.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/4AB0 indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-30
Employees	57,000
Employees change	5,000
Employees growth	10%
Enterprise value	EUR 512B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA00288K1084
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Market cap	EUR 454.2B
Next earnings date	2026-10-30
Price	EUR 24.60
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	fra/4AB0
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.23%
EV/Earnings	93.29x
EV/EBIT	24.92x
EV/EBITDA	18.31x
EV/FCF	32.12x
EV/Sales	8.86x
FCF / EV yield	3.11%
FCF yield	3.51%
Forward P/E	19.06x
Lynch fair value	EUR 1.49
Lynch upside	-93.96%
P/(FCF - SBC) ratio	30.11x
P/(OCF - SBC) ratio	28x
P/E ratio	81.27x
P/FCF ratio	28.5x
P/OCF ratio	26.6x
P/S ratio	8.06x
Price/EBITDA ratio	16.87x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	27.57%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	EUR 96,283
Profitable quarters	6
Profitable years	17
Revenue per employee	EUR 988,720
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.1B
Depreciation and amortization	EUR 7.1B
EBIT	EUR 20B
EBITDA	EUR 26.9B
EPS	EUR 0.30
Financing cash flow	EUR -11.3B
Free cash flow	EUR 15.9B
Free cash flow minus SBC	EUR 15.1B
Gross profit	EUR 41B
Income taxes	EUR 2.1B
Investing cash flow	EUR -5.7B
Net borrowing	EUR 375.4M
Net cash flow	EUR 89.3M
Net income	EUR 5.5B
Operating cash flow minus SBC	EUR 16.2B
Operating income	EUR 20B
Revenue	EUR 56.4B
Stock-based compensation	EUR 854.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	EUR -2.94
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	EUR 31.9B
Interest coverage	7.85
Long-term assets	EUR 88B
Long-term liabilities	EUR 86B
Net cash (debt)	EUR -56.3B
Net cash / market cap	-12.39%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	EUR 5.2B
Shareholders' equity	EUR -5.2B
Tangible book value	EUR -79.3B
Tangible book value per share	EUR -44.87
Total assets	EUR 118.3B
Total cash	EUR 5.7B
Total debt	EUR 62B
Total liabilities	EUR 123.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	EUR 30.2B
Current liabilities	EUR 37.4B
Current ratio	0.81
Inventory turnover	3.47
Net working capital	EUR -5.4B
Quick ratio	0.49
Working capital	EUR -7B
Working capital turnover	-6.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	-0.64%
Dividend growth (3Y)	-0.33%
Dividend growth years	0
Dividend payment date	2026-11-23
Dividend payment years	4
Dividend payout frequency	Quarterly
Dividend per share	EUR 0.59
Dividend yield	2.42%
Ex-dividend date	2026-10-15
Last dividend	EUR 0.15
Payout ratio	189.83%
Shareholder yield	2.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 19.75
1D price change	-0.81%
1M price change	14.82%
1M total return	15.58%
1W price change	-3.13%
1W total return	-3.13%
1Y price change	30.53%
1Y return CAGR	34.66%
1Y total return	34.63%
20-day SMA	EUR 22.83
200-day SMA	EUR 19.54
3M price change	5.09%
3M total return	5.78%
3Y price change	73.43%
3Y return CAGR	24.37%
3Y total return	92.38%
50-day SMA	EUR 21.96
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 25.60
52-week high date	2026-10-19
52-week low	EUR 16.40
52-week low date	2026-05-11
6M price change	49.4%
6M total return	51.5%
All-time high	EUR 25.60
All-time high date	2026-10-19
All-time low	EUR 12.70
All-time low date	2023-11-16
Average true range (ATR)	EUR 0.66
Average volume	9
Change from 52-week high	-3.91%
Change from 52-week low	50%
Change from all-time high	-3.13%
Change from all-time low	95.28%
Change from open	1.65%
Day's gap	-2.42%
High price	EUR 24.60
Low price	EUR 24.20
Monthly RSI	69.18
Open price	EUR 24.20
Position in 52-week range	100%
Previous close	EUR 24.80
Price vs 150-day SMA	25.58%
Price vs 20-day SMA	8.63%
Price vs 200-day SMA	26.92%
Price vs 50-day SMA	12.91%
Relative volume	0.56
RSI	62.42
Sharpe ratio	0.86
Sharpe ratio (3Y)	0.59
Sortino ratio	1.52
Sortino ratio (3Y)	1.04
Volume	0
Weekly RSI	69.76
YTD price change	29.17%
YTD total return	33.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.58%
Short ratio	3.2 days

Deeper analysis on FRA/4AB0

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/4AB0 report

Is a complete FRA/4AB0 research report available?

No complete published report is available for fra/4AB0 (FRA/4AB0) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/4AB0 (FRA/4AB0)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/4AB0

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/4AB0 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/4AB0

Frequently asked questions